Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors
By A. Spaan, J. Strijp, Victor J. Torres. 2017
311 citations recorded by the source corpus.
Subfields: Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Molecular Biology
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes (2020, unknown): “aureus isolates has five members: LukSF-PV (or PVL), LukED, HlgAB, HlgCB, and LukAB (or LukHG) (4, 5).”
- Staphylococcus aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin (2019, background): “S. aureus clinical isolates, including USA300 (11), produce up to five different leukocidins: leukocidin ED (LukED), PantonValentine leukocidin (PVL), leukocidin AB (LukAB, also known as LukGH), and -hemolysins AB and CB (HlgAB and HlgCB) (9, 10).”
- Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies (2017, background): “The other five pore forming cytotoxins – Leukocidin SF-PV (Panton-Valentine leukocidin), ED and GH (the latter also called LukAB) and the two gamma-hemolysins (HlgAB and HlgCB) – all target leukocytes, and primarily attack phagocytic cells, such as granulocytes, macrophages, and monocytes.(11) In ad”